On Jan 11, 2022 Freenome closed a Corporate Round round and raised $290,000,000 from Roche, featuring lead investors Roche.

About the company: Freenome is located at United States, North America.
“Freenome is a biotechnology company based in South San Francisco that has
pioneered the most comprehensive multiomics platform for early cancer
detection with a simple blood test.”

Company website: http://www.freenome.com

Leave a Reply

Your email address will not be published.